Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 97,934 shares at $2.20 ($215K) on 2023-08-09, disclosed to the SEC on 2023-08-10.
Open-market sale of $215k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 48,967 | $108K | 50.0% |
| 2 | $2.20 | 48,967 | $108K | 50.0% |
| Total | $2.20 avg | 97,934 | $215K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $753K | — | Filing → |